Aspirin Manufacturer Bayer to Buy Teva’s US Animal Health Business

Sept. 14, 2012
German firm will pay $60 million initially, with a further $85 million tied to agreed manufacturing and sales targets.

German pharmaceuticals giant Bayer (IW 1000/88), best known for its Aspirin painkiller, agreed Friday to buy the U.S. animal health business of Israeli generic drug specialist Teva (IW 1000/243) for $145 million.

The German firm said the deal, which concerns a manufacturing site in St. Joseph, Mo., would "strengthen Bayer HealthCare's companion animal franchise."

Bayer will pay $60 million upfront, with a further $85 million tied to agreed manufacturing and sales targets.

The Missouri site employs a workforce of 300, and the transaction is set to be completed in 2013, pending antitrust clearance, Bayer added.

Copyright Agence France-Presse, 2012

Popular Sponsored Recommendations

Global Supply Chain Readiness Report: The Pandemic and Beyond

Sept. 23, 2022
Jabil and IndustryWeek look into how manufacturers are responding to supply chain woes.

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

How Organizations Connect and Engage with Frontline Workers

June 14, 2023
Nearly 80% of the 2.7 billion workers across manufacturing, construction, healthcare, transportation, agriculture, hospitality, and education are frontline. Learn best practices...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!